Literature DB >> 12530469

Pien Tze Huang protects the liver against carbon tetrachloride-induced damage.

Kenneth K H Lee1, Wing Hang Kwong, Foo-tim Chau, David T Yew, Wood Yee Chan.   

Abstract

Pien Tze Huang, a traditional Chinese medicine, has been extensively used as a therapeutic drug in the treatment of liver diseases. In this study, we have examined its ability to protect the liver from carbon tetrachloride (CCl4)-induced damage in the mouse. Histological observations revealed that CCl4 treatment induced extensive degenerative changes in the hepatocytes surrounding the central veins of the liver. However, these changes were much reduced by more than 28% in mice fed with 0.5 mg of Pien Tze Huang/g body weight/dose (3 doses over 36 hr) prior to CCl4 treatment. The effects of Pien Tze Huang were then further investigated in a hepatoma cell line. Flow analysis showed that it had no significant effects on cell proliferation. When the ability of Pien Tze Huang to influence various response elements of important signal transduction pathways was examined in the hepatoma cell line, it was found that Pien Tze Huang stimulated an increase in the response of AP1, CRE and NFkappaB responsive elements. The transcriptional factors of these responsive elements are known to play important roles in regulating cell death and survival. We thus postulate that the ability of Pien Tze Huang to protect the liver from damage is attained through its ability to modulate the activity of these important signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12530469     DOI: 10.1034/j.1600-0773.2002.910406.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  10 in total

1.  Pien Tze Huang induced apoptosis in human colon cancer HT-29 cells is associated with regulation of the Bcl-2 family and activation of caspase 3.

Authors:  Jiu-mao Lin; Li-hui Wei; You-qin Chen; Xian-xiang Liu; Zhen-feng Hong; Thomas J Sferra; Jun Peng
Journal:  Chin J Integr Med       Date:  2011-09-11       Impact factor: 1.978

2.  Protective effects and potential mechanisms of Pien Tze Huang on cerebral chronic ischemia and hypertensive stroke.

Authors:  Lihong Zhang; Wai Ping Lam; Lanhai Lü; Chunmei Wang; Yeuk Wa Wong; Lok Hang Lam; Hong Chai Tang; Maria Sen Mun Wai; Mingwei Wang; Wing Hang Kwong; Sai Ming Ngai; Ying Tat Mak; David Tai Wai Yew
Journal:  Chin Med       Date:  2010-10-18       Impact factor: 5.455

Review 3.  Recent Progress of Research on Herbal Products Used in Traditional Chinese Medicine: the Herbs belonging to The Divine Husbandman's Herbal Foundation Canon ( Shén Nóng Běn Cǎo Jīng).

Authors:  Kuo-Hsiung Lee; Susan Morris-Natschke; Keduo Qian; Yizhou Dong; Xiaoming Yang; Ting Zhou; Eileen Belding; Shou-Fang Wu; Koji Wada; Toshiyuki Akiyama
Journal:  J Tradit Complement Med       Date:  2012-01

4.  Therapeutic Potential of Pien Tze Huang on Experimental Autoimmune Encephalomyelitis Rat.

Authors:  Xuemei Qiu; Hui Luo; Xue Liu; Qingqing Guo; Kang Zheng; Danping Fan; Jiawen Shen; Cheng Lu; Xiaojuan He; Ge Zhang; Aiping Lu
Journal:  J Immunol Res       Date:  2018-02-27       Impact factor: 4.818

5.  Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells.

Authors:  Xuemei Qiu; Qingqing Guo; Xue Liu; Hui Luo; Danping Fan; Yongqi Deng; Hua Cui; Cheng Lu; Ge Zhang; Xiaojuan He; Aiping Lu
Journal:  Front Pharmacol       Date:  2018-10-31       Impact factor: 5.810

Review 6.  Pien Tze Huang (PZH) as a Multifunction Medicinal Agent in Traditional Chinese Medicine (TCM): a review on cellular, molecular and physiological mechanisms.

Authors:  Zhiliang Chen
Journal:  Cancer Cell Int       Date:  2021-03-03       Impact factor: 5.722

7.  Reaction of the Liver upon Long-Term Treatment of Fluoxetine and Atorvastatin Compared with Alcohol in a Mouse Model.

Authors:  Zhiliang Chen; Tony C H Chow; Shicong Wang; Gigi C T Leung; Sharon L Y Wu; David T Yew
Journal:  J Toxicol       Date:  2021-12-30

8.  Pien-Tze-Huang alleviates CCl4-induced liver fibrosis through the inhibition of HSC autophagy and the TGF-β1/Smad2 pathway.

Authors:  Yuqin Zhang; Liping Hua; Chunfeng Lin; Mingzhou Yuan; Wei Xu; Anand Raj D; Baskar Venkidasamy; Carlos L Cespedes-Acuna; Shivraj Hariram Nile; Guohong Yan; Haiyin Zheng
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

9.  Inhibition of ovarian cancer cell proliferation by Pien Tze Huang via the AKT-mTOR pathway.

Authors:  Fan He; Hui-Ni Wu; Mu-Yan Cai; Chang-Peng Li; Xin Zhang; Quan Wan; Shuang-Bo Tang; Jian-Ding Cheng
Journal:  Oncol Lett       Date:  2014-03-21       Impact factor: 2.967

Review 10.  Therapeutic Potential of Pien-Tze-Huang: A Review on Its Chemical Composition, Pharmacology, and Clinical Application.

Authors:  Lili Huang; Yiping Zhang; Xiaoqin Zhang; Xiuping Chen; Yitao Wang; Jinjian Lu; Mingqing Huang
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.